REG - GSK PLC - Result of AGM

GSKAnnouncement

Wed 18:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250507:nRSG7755Ha&default-theme=true

RNS Number : 7755H  GSK PLC  07 May 2025

GSK plc

 

Results of 25(th) Annual General Meeting

 

GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on
Wednesday 7 May 2025 at The Landmark London, 222 Marylebone Road, London, NW1
6JQ. Shareholders were able to join the meeting in person or virtually via the
Lumi AGM website and Zoom.

 

All valid proxy votes (whether submitted electronically or in hard copy form)
were included in the poll taken at the meeting.

 

All 25 resolutions were passed and decided upon by a poll. The table below
shows the results for each resolution. The full text of the resolutions is
contained in the Notice of AGM published on 24 March 2025, which is available
on GSK's website at www.gsk.com (http://www.gsk.com) .

 

 Resolution                                                                           Total votes for((1)(2))  %      Total votes against((2))  %     Total votes cast  % of Issued Share Capital voted((3))  Votes withheld((4))
 1       Receive and adopt the 2024 Annual Report                                     3,031,647,740            99.82  5,472,209                 0.18  3,037,119,949     73.91%                                12,204,390
 2       Approve the Annual report on remuneration                                    2,810,183,626            92.46  229,176,108               7.54  3,039,359,734     73.97%                                9,979,421
 3       Approve the Remuneration policy                                              2,786,567,742            93.10  206,384,696               6.90  2,992,952,438     72.84%                                56,376,703
 4       Election of Dr Gavin Screaton                                                3,040,206,238            99.89  3,385,136                 0.11  3,043,591,374     74.07%                                5,719,426
 5       Re-election of Sir Jonathan Symonds                                          2,947,917,394            98.40  48,075,530                1.60  2,995,992,924     72.91%                                53,319,043
 6       Re-election of Dame Emma Walmsley                                            3,038,248,728            99.82  5,613,533                 0.18  3,043,862,261     74.08%                                5,444,311
 7       Re-election of Julie Brown                                                   3,034,344,765            99.69  9,515,889                 0.31  3,043,860,654     74.08%                                5,460,463
 8       Re-election of Elizabeth McKee Anderson                                      2,941,679,748            96.64  102,161,424               3.36  3,043,841,172     74.08%                                5,465,676
 9       Re-election of Charles Bancroft                                              2,956,308,387            97.13  87,450,752                2.87  3,043,759,139     74.07%                                5,553,709
 10      Re-election of Dr Hal Barron                                                 3,039,339,475            99.85  4,466,176                 0.15  3,043,805,651     74.08%                                5,489,801
 11      Re-election of Dr Anne Beal                                                  2,955,431,838            97.09  88,492,673                2.91  3,043,924,511     74.08%                                5,388,566
 12      Re-election of Wendy Becker                                                  2,933,164,994            96.36  110,745,350               3.64  3,043,910,344     74.08%                                5,400,009
 13      Re-election of Dr Harry C Dietz                                              3,039,383,688            99.86  4,369,000                 0.14  3,043,752,688     74.07%                                5,560,851
 14      Re-election of Dr Jeannie Lee                                                3,039,577,387            99.86  4,161,377                 0.14  3,043,738,764     74.07%                                5,574,652
 15      Re-election of Dr Vishal Sikka                                               3,038,858,707            99.84  4,756,490                 0.16  3,043,615,197     74.07%                                5,688,803
 16      Re-appointment of the auditor                                                3,025,673,462            99.89  3,223,574                 0.11  3,028,897,036     73.71%                                20,430,064
 17      Remuneration of the auditor                                                  3,039,931,435            99.88  3,782,302                 0.12  3,043,713,737     74.07%                                5,591,584
 18      Authority for the company to make donations to political organisations and   2,946,755,927            99.01  29,581,561                0.99  2,976,337,488     72.43%                                72,977,673
         incur political expenditure
 19      Authority to allot shares                                                    2,899,903,495            95.30  143,133,156               4.70  3,043,036,651     74.06%                                6,282,441
 20      Disapplication of pre-emption rights - general power((5))                    2,941,521,597            96.72  99,811,731                3.28  3,041,333,328     74.02%                                7,942,085
 21      Disapplication of pre-emption rights - in connection with an acquisition or  2,962,038,875            97.39  79,351,038                2.61  3,041,389,913     74.02%                                7,904,048
         specified capital investment((5))
 22      Authority for the company to purchase its own shares((5))                    3,036,538,826            99.83  5,280,936                 0.17  3,041,819,762     74.03%                                7,499,989
 23      Exemption from statement of senior statutory auditor's name                  3,022,840,749            99.74  7,951,051                 0.26  3,030,791,800     73.76%                                18,502,136
 24      Authority for reduced notice of a general meeting other than an AGM((5))     2,863,892,275            94.11  179,242,127               5.89  3,043,134,402     74.06%                                6,172,307
 25      Approve the adoption of the GSK Share Value Plan                             2,972,805,515            99.56  13,033,137                0.44  2,985,838,652     72.67%                                63,503,752

 

 

Notes:

 

(1)      The "for" votes include those giving the Chair discretion.

(2)      Votes "for" and "against" are expressed as a percentage of the
total votes cast.

(3)      The Company's issued share capital as at 2 May 2025 consisted of
4,109,037,095 shares of 31 ¼ pence each ('Ordinary Shares') excluding
Ordinary Shares held in Treasury. Every shareholder has one vote for every
Ordinary Share held.

(4)    A "vote withheld" is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a resolution.

(5)      Indicates Special Resolutions requiring a 75% majority of votes
cast.

 

 

The following table provides further information on participation in the AGM:

 

                                                                          GSK's 25(th) AGM            GSK's 24(th) AGM

                                                                          (Hybrid meeting)            (Hybrid meeting)

                                                                          (2025)                      (2024)
 Issued share capital (excluding Treasury Shares)                         4,109,037,095               4,314,108,510

 Total votes cast and votes withheld lodged as a % of GSK's issued share  74.21%                      73.11%
 capital (excluding Treasury Shares)
 Total shareholder population                                             86,241                      60,448
 Total number of proxies lodged                                           3,743                       2,886
 Number of shareholders in attendance                                     130 in person               125 in person

                                                                          25 participated virtually   38 participated virtually
 % of shareholders who lodged proxies                                     4.34%                       4.77%

 

 

The above poll results will shortly be available on the company's website at
www.gsk.com (http://www.gsk.com) .

 

In accordance with Listing Rule 6.4.2 of the Financial Conduct Authority's
(FCA) Listing Rules, a copy of the resolutions, other than those concerning
ordinary business, will be submitted to the FCA and will, in due course, be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 

V A Whyte

Company Secretary

7 May 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGARMRTMTTMBBA